Ondine Biomedical, Inc. (GB:OBI) has released an update.
Ondine Biomedical Inc. has announced board changes, with Margaret Shaw reappointed and Craig Tooman resigning due to increased responsibilities at Silence Therapeutics. Shaw, an experienced finance professional, is expected to bring strategic vision and financial expertise to the company as it continues to grow and tackle healthcare-associated infections and antimicrobial resistance. The company is advancing its photodisinfection technologies, with Shaw’s appointment contributing to diversity goals and providing valuable insights as the company navigates FDA approval processes.
For further insights into GB:OBI stock, check out TipRanks’ Stock Analysis page.
